Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Conditions

• Hand, Foot and Mouth Disease (HFMD)
• HFMD
• Hand, Foot and Mouth Disease

Interventions

• BIOLOGICAL: Low Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
• BIOLOGICAL: Medium Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
• BIOLOGICAL: High Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
• BIOLOGICAL: Placebo

Sponsor

Institute of Medical Biology, Chinese Academy of Medical Sciences

Collaborators

• [object Object]